Pts Diagnostics India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -14.86%
(FY 2021)
- Profit 5.35%
(FY 2021)
- Ebitda -8.59%
(FY 2021)
- Net Worth -34.91%
(FY 2021)
- Total Assets 46.19%
(FY 2021)
About Pts Diagnostics India
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kobi Roy, Kuntal Das, and Ashvnee Bhadouria serve as directors at the Company.
- CIN/LLPIN
U29304HR2016PTC086340
- Company No.
094952
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pts Diagnostics India Private Limited offer?
Pts Diagnostics India Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Pts Diagnostics India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kobi Roy  | Director | 20-Apr-2022 | Current |
| Kuntal Das | Director | 29-Sep-2024 | Current |
| Ashvnee Bhadouria | Additional Director | 15-Nov-2024 | Current |
Financial Performance of Pts Diagnostics India.
Pts Diagnostics India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 14.86% decrease. The company also saw a slight improvement in profitability, with a 5.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pts Diagnostics India?
In 2021, Pts Diagnostics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pts Diagnostics India?
Pts Diagnostics India has a workforce of 35 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pts Diagnostics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pts Diagnostics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
